MedPage Today on MSN
Another IL-17A/F Blocker Moves Forward for Psoriatic Arthritis
Called sonelokimab, the product inhibits both the A and F isoforms of interleukin-17 (IL-17). In this mid-stage trial, well ...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A PANEL DISCUSSION The Summit theme “unlocking the $1 Trillion Wealth ...
Discover BioVie's latest clinical advancements in Parkinson's, long COVID, and ascites. Learn about investment potential and upcoming data readouts.
BioVie Inc. - Special CallCompany ParticipantsCuong Viet Do - President, CEO & DirectorConference Call ParticipantsCraig ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback